Joseph C. Presti

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Keith Syson Chan, Íñigo Espinosa, Mark P. Chao et al. · Proceedings of the National Academy of Sciences · 2009 · 673 citations · Full text

Clinical Prognosis, Cancer Biology, Molecular Heterogeneity +16

THE OPTIMAL SYSTEMATIC PROSTATE BIOPSY SCHEME SHOULD INCLUDE 8 RATHER THAN 6 BIOPSIES: RESULTS OF A PROSPECTIVE CLINICAL TRIAL

Joseph C. Presti, JAMES J. CHANG, Vivek Bhargava et al. · The Journal of Urology · 2000 · 497 citations

Long-Term Outcomes From a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer

Christopher King, James D. Brooks, Harcharan Gill et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 402 citations

Urology, Surgical Oncology, Radiation Therapy +9

Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group

Stephen J. Freedland, William J. Aronson, Christopher J. Kane et al. · Journal of Clinical Oncology · 2003 · 387 citations

Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer

Lionel L. Bañez, Robert J. Hamilton, Alan W. Partin et al. · JAMA · 2007 · 353 citations